Anti-TNF therapy for severe acute alcoholic hepatitis: what went wrong?
Blendis
Laurie
L
Dotan
Iris
I
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006519:Hepatitis, Alcoholic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D009336:Necrosis; D011379:Prognosis; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab